Moderate Emetic Risk Intravenous Antineoplastic Agent

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.223" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.153" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200" ]
    }, {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168" ]
    } ]
  },
  "date" : "2024-10-10T01:07:42-04:00",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2024-10-10T01:07:42.000-04:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "name" : "ModerateEmeticRiskIntravenousAntineoplasticAgent",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1191138",
      "display" : "doxorubicin hydrochloride 2 MG/ML Injectable Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1594658",
      "display" : "1.2 ML alemtuzumab 10 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1660004",
      "display" : "thiotepa 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1660009",
      "display" : "thiotepa 15 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1718589",
      "display" : "trabectedin 1 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1719772",
      "display" : "10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1726097",
      "display" : "bendamustine hydrochloride 25 MG/ML Injectable Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1726319",
      "display" : "2 ML irinotecan hydrochloride 20 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1726324",
      "display" : "5 ML irinotecan hydrochloride 20 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1726333",
      "display" : "15 ML irinotecan hydrochloride 20 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1726492",
      "display" : "25 ML irinotecan hydrochloride 20 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1732182",
      "display" : "25 ML epirubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1732186",
      "display" : "100 ML epirubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1736776",
      "display" : "10 ML oxaliplatin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1736781",
      "display" : "20 ML oxaliplatin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1736784",
      "display" : "oxaliplatin 50 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1736786",
      "display" : "oxaliplatin 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790095",
      "display" : "doxorubicin hydrochloride 50 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790097",
      "display" : "5 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790099",
      "display" : "10 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790100",
      "display" : "25 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790103",
      "display" : "doxorubicin hydrochloride 10 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791493",
      "display" : "20 ML idarubicin hydrochloride 1 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791498",
      "display" : "10 ML idarubicin hydrochloride 1 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791500",
      "display" : "5 ML idarubicin hydrochloride 1 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791588",
      "display" : "ifosfamide 3000 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791593",
      "display" : "ifosfamide 1000 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791597",
      "display" : "60 ML ifosfamide 50 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1791599",
      "display" : "20 ML ifosfamide 50 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1797528",
      "display" : "40 ML oxaliplatin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1805001",
      "display" : "bendamustine hydrochloride 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1805007",
      "display" : "bendamustine hydrochloride 25 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1872062",
      "display" : "doxorubicin hydrochloride 20 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1942743",
      "display" : "cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1992545",
      "display" : "6 ML arsenic trioxide 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2002002",
      "display" : "10 ML daunorubicin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2267576",
      "display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2289413",
      "display" : "5.5 ML romidepsin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "249364",
      "display" : "20 ML cytarabine 100 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "253113",
      "display" : "10 ML busulfan 6 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "309650",
      "display" : "4 ML daunorubicin 5 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "485246",
      "display" : "azacitidine 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "486419",
      "display" : "20 ML clofarabine 1 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "597195",
      "display" : "carboplatin 10 MG/ML Injectable Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "828265",
      "display" : "1 ML alemtuzumab 30 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "829926",
      "display" : "10 ML arsenic trioxide 1 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "835945",
      "display" : "temozolomide 100 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "877513",
      "display" : "romidepsin 10 MG Injection",
      "version" : "11042024"
    } ],
    "total" : 48,
    "identifier" : "urn:uuid:40d77387-54e1-46d8-9374-78d3b5c8f932",
    "timestamp" : "2024-12-10T10:14:02-05:00"
  },
  "title" : "Moderate Emetic Risk Intravenous Antineoplastic Agent",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "American Society of Clinical Oncology Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-10-10",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2024-10-10",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "6a419239-e340-4a0c-8a71-09e1e90df1ca",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.1444.5.243"
  } ],
  "version" : "20241010"
}